Article: Futura Medical and GSK sign Med2002 development deal.(GlaxoSmithKline)(Brief article)

UK specialty drugmaker Futura Medical says that it has reached an agreement with GlaxoSmithKline under which the latter will pay 65% of the costs associated with the development of Med2002, Futura's topically-applied erectile ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!